baber/WOPTO huggingface dataset:
Patent EP-2492639-A1 (EP)
Inventor: FUCHS HEIKO
IPC: H04W4/21
Filed: 2011-02-22
Abstract: The contact-related language file package including voice messages (411,412) is received by a server computer from mobile user device (400) that codes the speech into a voice file. The communication between the users and the behavior of the user are determined by the contact weight assigned to the contact of the user. The contact-related language file package is sent to another mobile user device depending on the result of comparison of the content to the requesting descriptive characterizing feature received from another user device and the contact weight. Independent claims are included for the following: (1) server computer; and (2) mobile user device.
Patent EP-2495942-A1 (EP)
Inventor: PEGG ALBERT
IPC: H04M1/02
Filed: 2011-03-04
Abstract: A portable electronic device, including a first portion having a first surface, a second portion having a second surface, and a slide portion coupled to the first and second portions. The first portion, second portion and slide portion are adapted so that the first portion can rotate between a closed position wherein the first portion at least partially covers the second surface, and a rotated position wherein the second surface is at least partially exposed, and wherein, when the first portion is in the rotated position, the first portion and slide portion can slide relative to the second portion along a slide direction to an open position in which the first surface and second surface are aligned.
Patent EP-2337061-A1 (EP)
Inventor: STARK ROLAND
IPC: H01K1/46
Filed: 2008-07-16
Abstract: The electrical lamp (1) has an external piston supported in a socket (2). An installation lamp (4) such as a high voltage halogen lamp, is clamped within the external piston by an assembly-clip (6). The assembly clip is fixed at a circular base (5) exhibiting a lower cylindrical region (8) and an upper region (9). A cross section area of the upper region is smaller than that of the lower region. The assembly clip is fixed to the upper region of the circular base.
Patent EP-2377700-A1 (EP)
Inventor: GHINAMO PAOLO
IPC: B60G21/06
Filed: 2011-04-15
Abstract: A modular convoy (1) for outsize loads is formed by connecting a first tyred trailer (3) and at least a second (4) tyred trailer to each other, having first (6) and second hydraulic suspensions (10), respectively, which are reciprocally different; each of the first suspensions (6) having a first lever transmission (7) and a first simple-acting, linear hydraulic actuator (8) to exert on the ground a first load support action, and each of the second hydraulic suspensions (10) having a second mechanical lever transmission (11) and a second double-effect, linear hydraulic actuator (12), the chambers (15)(16) of which are connected to the same feeding line (21) for exerting on the ground a second load support action which is substantially equal to the first support action.
Patent EP-2514461-A1 (EP)
IPC: A61M5/34
Filed: 2011-04-20
Abstract: Described is a needle assembly (A) comprising a needle hub (1) having a coupling mechanism adapted to engage corresponding coupling mechanism of a retainer (2), and a notch (6) formed in a proximal end of the needle hub (1), wherein the notch (6) is adapted to engage a projection (5) on the retainer (2).
Patent EP-2522230-A1 (EP)
Inventor: PICKFORD KEITH
IPC: A23L29/281
Filed: 2011-05-13
Abstract: A microwave cookable or reheatable foodstuff coating composition comprises 55 to 80 wt% water and 20 to 45 wt% by dry weight of an ingredient mixture including: 
a. 35 to 60 wt% of a flour component comprising one or more flours selected from soy flour, maize flour, rice flour and wheat flour; 
b. 15 to 35 wt% of non-modified starch; 
c. 0.1 to 5 wt% of a gelling agent; 
d. 0 to 15 wt% of modified starch; and 
e. 0 to 35 wt% of other edible ingredients.
Patent EP-2397377-A1 (EP)
Inventor: KOESTLER ULRICH
IPC: B60R21/38
Filed: 2011-06-08
Abstract: The hinge (10) has two hinge parts (12,14) that are connected with each other in an articulated manner and are movable relative to each other between a normal position and a protective position. The hinge parts are fixed in the normal position by a holding unit under impact with a holding force between the hinge parts. An independent claim is also included for a method for actuating a hinge.
Patent EP-2535717-A1 (EP)
Inventor: BOEGER RAINER
IPC: G01N33/68
Filed: 2011-06-13
Abstract: The present invention generally relates to methods for determining the mortality risk in a subject. In one aspect, the invention relates to a method for determining/predicting the all-cause mortality risk of a test subject based on the detection of pathologically decreased expression levels of the gene encoding the alanine-glyoxylate-aminotransferase 2 (AGXT2) and/or pathologically decreased activity levels of the AGXT2 enzyme. In a further aspect, the invention relates to a method for determining/predicting the all-cause mortality risk of a test subject based on the detection of genetic alterations which are associated with such pathologically decreased expression levels and/or activity levels. Finally, the invention also relates to compounds which are effective in increasing the expression of the AGXT2 gene and/or the activity of the AGXT2 enzyme for use in a method of decreasing the mortality risk of a subject.
Patent EP-2546915-A1 (EP)
Inventor: HANNESEN UWE
IPC: H01M8/24
Filed: 2011-07-11
Abstract: The present invention relates to a housing assembly for at least two fuel cells, comprising: 
- a hollow profile-like body (12) extending in an axial direction (z) and being adapted to laterally encompass at least two fuel cells stacked on one another in axial direction (z), and 
- a fastening mechanism to interconnect the body (12) with at least one end plate (18, 28) adapted to support the at least two fuel cells.
Patent EP-2384768-A1 (EP)
Inventor: ZHOU XIAOMING
IPC: A61K45/06
Filed: 2007-10-31
Abstract: The invention relates to phenylpropionamide compounds of Formula I:
     
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein A, B, R 1 , R 2 , R 3 , R 4  and R 5  are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the activation of opioid receptors, particularly µ-opioid receptors. Compounds of the present invention are especially useful for treating pain.
Patent EP-2397949-A1 (EP)
Inventor: GUO HONGSHI
IPC: G06F13/42
Filed: 2007-05-25
Abstract: Techniques for performing flow control in Universal Serial Bus (USB) are described. In one design, a USB host sends token packets to a USB device to initiate data exchanges with the USB device. The USB device determines that it is incapable of exchanging data with the USB host, e.g., because there is no data to send or because its buffer is full or near full. The USB device then sends a "flow off' notification to the USB host to suspend data exchanges. The USB host receives the flow off notification and suspends sending token packets to the USB device. Thereafter, the USB device determines that it is capable of exchanging data with the USB host. The USB device then sends a "flow on" notification to the USB host to resume data exchanges. The USB host receives the flow on notification and resumes sending token packets to the USB device.
Patent EP-2446897-A1 (EP)
Inventor: ROMAGNE FRANCOIS
IPC: A61K38/20
Filed: 2006-01-06
Abstract: Compositions comprising anti-KIR antibodies and one or more secondary anti-cancer agents or anti-viral agents and methods of using such combinations (as combination compositions or in separate administration protocols) in the treatment of cancers (e.g., lung cancer) or viral infection (e.g., HIV or HCV infection) are provided.
Patent EP-2570126-A1 (EP)
Inventor: RASSOULIAN DARIUS
IPC: A61K9/00
Filed: 2011-09-16
Abstract: The present invention relates to melatonine or a pharmaceutically acceptable salt thereof for use as a medicament, the use of melatonine or a pharmaceutically acceptable salt thereof for the preparation of medicament, the use of melatonine as a food supplement and a pharmaceutical unit dosage form.
Patent EP-2433850-A1 (EP)
Inventor: TAKEDA TOMOYA
IPC: B62D25/08
Filed: 2011-09-28
Abstract: A torque rod mounting structure for mounting an end (21) of a torque rod (13) to a vehicle body (18) includes a bracket assembly (15) having a pair of vertically spaced upper and lower brackets (37, 38) attached to and projecting from a damper housing (28) and connected at respective front end portions thereof to the end of the torque rod. The bracket assembly also includes a stay bracket (42) connected at one end to the damper housing below the lower bracket and, at an opposite end, to the front end portion of the lower bracket. The stay bracket is configured to form, together with the damper housing, a hollow portion having a closed cross section.
Patent EP-2404901-A1 (EP)
Inventor: MOGI MUNETO
IPC: C07D403/12
Filed: 2008-12-01
Abstract: The present invention provides a compound of formula (I):
     
wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
Patent EP-2404602-A1 (EP)
Inventor: BEACHY PHILIP ARDEN
IPC: A61K31/44
Filed: 2006-08-22
Abstract: The present invention relates to itraconazole or a pharmaceutically acceptable salt thereof for use in inhibiting hedgehog pathway activity related to cancer in a subject.
Patent EP-2455074-A1 (EP)
Inventor: CIFTER UEMIT
IPC: A61K9/00
Filed: 2011-11-04
Abstract: The present invention relates to topical pharmaceutical compositions comprising flurbiprofen or a pharmaceutically acceptable salt thereof and methyl salicylate. More specifically, the invention relates to topical pharmaceutical compositions of flurbiprofen and methyl salicylate characterized in that said composition comprises dimethyl sulfoxide and one or more gelling agent. Furthermore, the invention relates to process for preparing the said topical pharmaceutical compositions and its use for the treatment of pain and inflammatory symptoms associated with muscle-skeletol system, joint and soft-tissue disorders.
Patent EP-2471377-A1 (EP)
Inventor: STEGEL SIMON
IPC: A23G9/22
Filed: 2011-12-05
Abstract: The present invention refers to a process of temperature controlled treatment of liquid and/or kneadable substances, such as an ice cream production, an ice cream material pasteurization, and similar, and to an apparatus for carying out said process. Said process comprises input of material to be treated into a container, agitating said material in the container by means of an impeller with simultaneous supply/discharge of heat by means of a cool/heat generator, continuous reading temperature of said material by means of at least one temperature sensor, and controlling continuously said cool/heat generator by means of said controller.
Patent EP-2607953-A1 (EP)
Inventor: LAZARIDIS MIHAL
IPC: H04M1/02
Filed: 2011-12-23
Abstract: An assembly for a device having camera functionality, such as a portable wireless device, provides for affixation of an external camera lens to the device. A magnetic coupler is positioned at the device. The magnetic coupler exerts magnetic forces that affix the external camera lens in position. Removal forces in excess of the magnetic forces are applied to remove the external lens out of the affixation at the device.
Patent EP-2521059-A1 (EP)
Inventor: LETZELTER FREDERIC
IPC: G06F17/50
Filed: 2011-05-06
Abstract: It is provided a computer-implemented method for designing a CAD modeled object. The method comprises displaying several three-dimensional parametric shapes on a screen, wherein each of the several three-dimensional parametric shapes is divided in several portions, a different design operation being assigned to each portion; user-interacting with the screen; determining one portion upon a location of the user-interacting on a support, the determining being performed among all the portions; and performing, on the shape to which the determined portion belongs, the operation assigned to this portion. 
     Such a method makes the design of a CAD modeled object easier.
Patent EP-2567946-A1 (EP)
Inventor: GARTNER ELLIS
IPC: C09K23/14
Filed: 2011-09-08
Abstract: The invention provides a particulate material for the production of a cement foam which material comprises particles comprising, attached to the particle surface, a surfactant which renders the particles hydrophilic, the surfactant comprising a moiety which is hydrolysable under alkaline conditions, which surfactant, after loss of the moiety by alkaline hydrolysis, renders the particles partially hydrophobic
Patent EP-2583688-A1 (EP)
Inventor: HYOETY HEIKKI
IPC: A61K39/125
Filed: 2011-10-18
Abstract: The invention is directed to a vaccine comprising: i) coxsackie B virus CBV1 and CBV2, and ii) at least one coxsackie B virus selected from CBV3, CBV4, CBV5 and CBV6. The CBVs are present in the vaccine in inactivated form, in the form of a component of the virus or as an antibody against the virus. The vaccine is effective in preventing and treating type 1 diabetes. So is an anti-coxsackie B virus composition provided.
Patent EP-2547719-A1 (EP)
Title: Pellicules de grande qualité optique résistant aux produits chimiques
Inventor: NEUHAEUSER ACHIM
IPC: B29C48/425
Filed: 2011-02-09
Abstract: L'invention concerne un procédé de fabrication de pellicules plastiques ou de corps moulés plastiques transparents ayant une résistance aux produits chimiques particulièrement élevée, notamment une très bonne résistance aux émulsions huile dans l'eau ou aux émulsions eau dans l'huile, et une grande qualité optique.
Patent EP-2525917-A1 (EP)
Inventor: DOUJAK EDUARD
IPC: B04C3/00
Filed: 2011-01-19
Abstract: L'invention concerne un dispositif (5) et un procédé pour enlever des particules de matière de suspension, en particulier des particules fines et des particules très fines, d'un flux d'eau présentant des particules de matière en suspension dans une conduite d'eau sous pression (3) d'une centrale (2), un corps tubulaire (6) formant un canal d'écoulement (7) étant prévu dans la conduite d'eau sous pression (3), le canal d'écoulement (7) étant agencé principalement dans la direction axiale de la conduite d'eau sous pression (3) et un dispositif de production de turbulence (11), immobile, destiné à exciter une composante d'écoulement, agencée perpendiculairement à un sens d'écoulement principal (9), du flux d'eau, étant disposé dans le canal d'écoulement (7), et un dispositif de séparation (13) destiné à séparer les particules de matière en suspension portées radialement vers l'extérieur sous l'effet de la force centrifuge étant prévu dans le sens d'écoulement en aval du dispositif de production de turbulence (11).
Patent EP-2531118-A1 (EP)
Inventor: CATTANEO GIORGIO
IPC: A61B17/221
Filed: 2011-02-04
Abstract: The invention relates to a medical device for loosening concretions in hollow organs of the body, comprising at least one rotational symmetrical lattice structure (10) that is connected to a holding element (20) in a rotationally fixed manner and at least two intersecting filaments (11a, 11b) which are wound about a common rotational axis L, the filaments being connected to each other on at least two connecting points (12a, 12b) that are arranged spaced apart in the longitudinal direction of the lattice structure (10), wherein a first filament (11a) forms a first twist angle a and a second filament (11b) forms a second angle of twist ß that is at least different in sections from the first angle of twist a such that a first connection point (12a) is rotated about the common rotational axis L at the transition of the lattice structure (10) from a radially compressed state into a radially expanded state, or vice versa, relative to a second connecting point (12b). The invention further relates to a method for producing such a device, to a treatment system comprising such a device and to a method for producing a treatment system.
Patent EP-2529046-A1 (EP)
Title: Method of feeding thread to a sewing machine and sewing machine thread feed
Inventor: GOODWIN DAVID
IPC: D02G1/00
Filed: 2011-01-28
Abstract: A sewing machine thread feed for a supplying sewing thread to a sewing machine, the sewing thread including a low melting point filament and a textile filament, the feed comprising: a guide mechanism for guiding sewing thread to a needle of the sewing machine; first and second spools carrying first and second filaments respectively, one of the spools carrying a low- melt filament and the other carrying a textile filament; first and second retention mechanisms for retaining the first and second spools respectively in position against force applied to them when filament is drawn off; the first and second filaments run from the first and second spools respectively to the guide mechanism; wherein the first filament runs from the first spool, through the centre of the second spool, so that the action of the second filament, when being drawn off the second spool, causes inter-winding of the first and second filaments to create composite sewing thread.
Patent EP-2560995-A1 (EP)
Title: Essai pour l'identification d'inhibiteurs de lrrk2
Inventor: ALESSI DARIO
IPC: G01N33/68
Filed: 2011-04-19
Abstract: L'invention concerne un procédé d'estimation de l'effet d'un composé d'essai sur LRRK2 dans un système cellulaire, le procédé comprenant les étapes de a) estimation de l'effet de l'exposition du système cellulaire comprenant LRRK2 au composé d'essai sur l'état de phosphorylation de Ser910 et/ou Ser935 du LRRK2; et/ou b) estimation de l'effet de l'exposition du système cellulaire comprenant LRRK2 au composé d'essai sur la liaison du LRRK2 à un 14-3-3 polypeptide. Le procédé peut comprendre ou peut comprendre en plus l'étape d'estimation de l'effet de l'exposition du système cellulaire comprenant LRRK2 au composé d'essai sur la localisation subcellulaire de LRRK2. Le procédé est considéré comme étant utile dans l'estimation de l'effet d'inhibiteurs putatifs de LRRK2 dans des systèmes cellulaires, y compris des systèmes  in vivo .
Patent EP-2598646-A1 (EP)
Inventor: SCHAFFER STEFFEN
IPC: C09K23/00
Filed: 2011-07-20
Abstract: The invention relates to cells and nucleic acids and also use thereof for producing rhamnolipids, and also methods for producing rhamnolipids.
Patent EP-2595987-A1 (EP)
Inventor: TREU MATTHIAS
IPC: A61P35/00
Filed: 2011-07-22
Abstract: The present invention encompasses compounds of general formula (I) wherein the groups R 1  to R 3  and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
Patent EP-2541844-A1 (EP)
Inventor: TORIGOE KEISUKE
IPC: H04L12/28
Filed: 2011-02-21
Abstract: A communication equipment notifies a server equipment of a communication port to which a communication cable is connected. If another communication port as a connection partner of the notified communication port is not yet connected to the communication cable, the server equipment transmits a first notification instruction to another communication equipment having the said another communication port. The said another communication equipment indicates, in a viewable manner, a communication port corresponding to the first notification instruction as a communication port to which the communication cable is required to be connected.
Patent EP-2606046-A1 (EP)
Inventor: PRIEPKE HENNING
IPC: A61P29/00
Filed: 2011-08-19
Abstract: La présente invention concerne des composés de formule (I) et leur utilisation en tant qu'inhibiteurs de la prostaglandine E2 synthase-1 microsomale (mPGES-1), des compositions pharmaceutiques les contenant, et leur utilisation en tant que médicaments pour le traitement et/ou la prévention de maladies inflammatoires et de conditions associées. Dans la formule (I), A, M, W, R 1 , R 2 , R 6 , R 7  sont tels que définis dans la description.
Patent EP-2548529-A1 (EP)
Inventor: JINNO MAKOTO
IPC: A61B19/00
Filed: 2011-03-07
Abstract: A medical manipulator (10) includes a trigger lever (36) that is operated by hands, a shaft (18) that extends from a body in which the trigger lever (36) is provided, a tip operating unit (12) that is provided at a tip of the shaft (18) and includes an end effector (300) to which the operation of the trigger lever (36) is mechanically transmitted and in which the operation is performed, and a detection mechanism (400) that detects an operation state of the trigger lever (36).
Patent EP-2616459-A1 (EP)
Inventor: SOERGEL SEBASTIAN
IPC: A01P5/00
Filed: 2011-09-12
Abstract: The present invention relates to novel pyridine compounds of the formulae (I) and (II), to their salts, to their tautomers, to their N-oxides, and to the salts of these N-oxides or tautomers. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests. The invention also relates to a method for controlling invertebrate pests by using these compounds. The invention further relates to plant propagation material and to agricultural compositions comprising said compounds.
Patent EP-2612211-A1 (EP)
Title: Source de courant dotée d'une réjection de mode commun active
Inventor: BATKO IVAN
IPC: G01R33/07
Filed: 2011-08-30
Abstract: La présente invention a trait à une source de courant dotée d'une réjection de mode commun active qui utilise un principe selon lequel elle est dotée d'une branche pour la production du courant requis, vers la sortie (107) dont une extrémité de la charge (3) est connectée ; et d'une branche du circuit de compensation actif (ACC) (200), vers la sortie (203) dont l'autre extrémité de la charge (3) est connectée. Au moyen d'au moins une entrée (201) du circuit ACC (200), au moins un signal est détecté sur la charge et, par la suite, ce signal est traité de manière à ce que le résultat du traitement du ou des signaux provenant de la ou des entrées (201) représente de préférence la tension de mode commun, qui correspond à la paire de tensions aux bornes (1) et (2) de la charge (3), ou une tension proche de la tension de mode commun. Ce résultat est par la suite traité par des circuits de régulation du circuit ACC (200), qui le comparent à la valeur de potentiel de référence (4) et, à l'aide du principe de contre-réaction, définissent ladite tension sur la sortie (203), qui, à l'intérieur de la précision de réglage, mène à l'équivalence du potentiel de référence (4) et au potentiel correspondant au résultat du traitement du ou des signaux provenant de la ou des entrées (201).
Patent EP-2625163-A1 (EP)
Title: Procédé de préparation de (3s,3s')-4,4'-disulfanediylbis(acide 3-aminobutane-1-sulfonique)
Inventor: BALAVOINE FABRICE
IPC: C07C303/02
Filed: 2011-10-07
Abstract: La présente invention concerne un nouveau procédé de préparation de (3S, 3S')-4,4'-disulfanediylbis(acide 3-aminobutane-1-sulfonique) en cinq étapes à partir de (S)-éthyl-2-(benzyloxycarbonylamino)-4-(néopentyloxysulfonyl)butanoate A.
Patent EP-2560766-A1 (EP)
Title: Système, agencement et procédé de fixation de plaque d'usure
Inventor: FERNANDEZ RICARDO FRANCISCO DOBERTI
IPC: B02C17/22
Filed: 2011-04-19
Abstract: Le système de plaque d'usure selon l'invention comprend une plaque d'usure conçue pour être fixée à l'intérieur d'un broyeur. Un agencement de fixation comprend un élément d'accouplement allongé dont la première extrémité est disposée de façon à assurer sa fixation à la plaque d'usure de telle sorte que, ainsi fixé, l'élément d'accouplement soit disposé de manière à pivoter par rapport à la plaque d'usure. Une seconde extrémité de l'élément d'accouplement allongé se fixe au broyeur.